The inducible expression of a UBC (Ubiquitin C)-targeting shRNA led to tumor regression and significant long-term survival benefits in orthotopic ovarian tumors, demonstrating the potential of targeting UBC in treating ovarian cancer [54]. This evidence concerns the gene UBC and ovarian neoplasm.